Marty Nazzaro
Director de Operaciones en Inflammasome Therapeutics, Inc. .
Perfil
Marty Nazzaro is currently the Vice President-Operations at Inflammasome Therapeutics, Inc. He previously worked as a Manufacturing Director at Control Delivery Systems, Inc. and as an Operations Director at EyePoint Pharmaceuticals, Inc. from 2006 to 2009.
He obtained his undergraduate degree from Suffolk University.
Cargos activos de Marty Nazzaro
| Empresas | Cargo | Inicio |
|---|---|---|
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Director de Operaciones | 01/03/2020 |
Antiguos cargos conocidos de Marty Nazzaro.
| Empresas | Cargo | Fin |
|---|---|---|
Control Delivery Systems, Inc.
 Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Corporate Officer/Principal | - |
| EYEPOINT PHARMACEUTICALS, INC. | Director de Operaciones | - |
Formación de Marty Nazzaro.
| Suffolk University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Bolsa de valores
- Insiders
- Marty Nazzaro
